The recent decision to establish a single pivotal trial as the default evidentiary standard for Food and Drug Administration (FDA) approval marks a substantive shift in the architecture of regulatory proof. This marks a shift from replication‐based validation to a coherence‐based model of sufficiency, beyond a procedur...
Jean-Christophe Lega, Steeve Provencher, Bruno Falissard et al.· Fundamental & Clinical Pharm...· 0 citations
OBJECTIVE
To describe and characterize three partly coexisting evidentiary configurations in drug regulation and health technology assessment (HTA), and to examine the inferential consequences of the progressive shift from replication-based to coherence-oriented standards of proof.
STUDY DESIGN AND SETTING
Conceptual...
Jean-Christophe Lega, Arthur Gougeon, Claudina Michal et al.· Journal of Clinical Epidemio...· 0 citations
ABSTRACT Introduction Frequentist statistical tools still structure a large part of biomedical research, regulatory evaluation, and medical teaching, even though their correct interpretation remains uncertain among students, clinicians, and readers of the literature. This misunderstanding is usually attributed to pedag...
Jean-Christophe Lega, Sylvie Chevret· Journal of Evaluation In Cli...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.